SenesTech, Inc. (NASDAQ:SNES – Get Free Report) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 83,400 shares, an increase of 112.8% from the January 31st total of 39,200 shares. Based on an average daily volume of 149,000 shares, the days-to-cover ratio is currently 0.6 days. Currently, 9.2% of the company’s shares are short sold.
SenesTech Price Performance
NASDAQ SNES traded down $0.26 during mid-day trading on Friday, hitting $2.90. The company’s stock had a trading volume of 76,363 shares, compared to its average volume of 76,872. The company’s 50 day simple moving average is $3.14 and its 200 day simple moving average is $2.96. The company has a debt-to-equity ratio of 0.05, a quick ratio of 4.92 and a current ratio of 6.32. SenesTech has a twelve month low of $1.90 and a twelve month high of $9.80.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on SNES shares. HC Wainwright increased their target price on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. StockNews.com began coverage on SenesTech in a research note on Saturday. They set a “sell” rating on the stock.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- Ride Out The Recession With These Dividend KingsĀ
- Chaos and Cash: Finding Opportunity in Volatility
- What is the Dow Jones Industrial Average (DJIA)?
- Realty Income: An Anchor in Volatile Markets
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.